Lataa...
Brexpiprazole: so far so good
This article describes the role of a newly approved antipsychotic agent brexpiprazole in the treatment of schizophrenia and major depressive disorder. This drug has high affinity for 5-HT(1A), 5-HT(2A), D(2) and α(1B,2C) receptors. It displays partial agonism at 5-HT(1A) and D(2) receptors and poten...
Tallennettuna:
| Julkaisussa: | Ther Adv Psychopharmacol |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
SAGE Publications
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4749739/ https://ncbi.nlm.nih.gov/pubmed/26913177 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045125315614739 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|